Monday, 22 June 2026
GLP-1 access for Medicare, WHO air quality roadmap, Patient trust in surgery safety
- 01
Access to GLP-1 Medications for Medicare Beneficiaries
The New England Journal of Medicine has published an article discussing access to GLP-1 medications for Medicare beneficiaries. The article raises concerns about the implications of this access for prescribing practices and patient management. It highlights potential barriers that may affect the availability of these medications for patients. This topic is particularly relevant for clinicians considering treatment options for patients with conditions such as obesity and diabetes.
via NEJM
- 02
WHO Releases New Roadmap for Global Air Quality Improvement
The World Health Organization (WHO) has introduced a new roadmap aimed at enhancing global air quality indices. This initiative is significant for public health policy and addresses environmental health concerns. The roadmap outlines strategies to improve air quality, which can have widespread implications for health outcomes. Further details on the specific measures and targets are not provided in the source.
via NEJM
- 03
Trust and Vulnerability in Surgical Patient Safety
The Lancet discusses the inherent trust patients place in surgical teams when undergoing procedures, particularly in the context of breast cancer surgery. Patients surrender control of their bodies, relying on the expertise and care of medical professionals they may not know well. This trust is critical, especially for women facing urgent and life-threatening situations. The article highlights the importance of robust systems and processes to ensure patient safety during these vulnerable moments.
via The Lancet
- 04
Satendra Singh Advocates for Reframing Disability Perspectives
Satendra Singh, a physician and disability activist, emphasises the importance of reframing perceptions of disability through advocacy. Born with poliomyelitis, Singh views his impairment as a unique qualification for addressing challenges faced by individuals with disabilities. His experiences and insights aim to inspire a shift in how society perceives and supports people with disabilities. This perspective is particularly relevant for healthcare professionals in understanding and improving care for patients with disabilities.
via The Lancet
- 05
Obituary: Margaret Peden, Leader in Injury Prevention
Margaret Peden, a global leader in injury prevention research and advocacy, passed away on January 29, 2026, in Oxfordshire, UK, at the age of 64. Born on January 28, 1962, in East London, South Africa, Peden made significant contributions to the field of public health. Her work has influenced strategies for injury prevention worldwide, impacting both research and clinical practices.
via The Lancet
- 06
Correction issued for ENERGIZE trial investigator list
The Lancet has published a correction regarding the list of study investigators in the appendix of the article on Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia. This correction pertains to the phase 3, international, randomised, double-blind, placebo-controlled trial known as ENERGIZE. The update was officially made on June 18, 2026. This correction is relevant for those referencing the trial's findings and investigator contributions.
via The Lancet
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.